Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Trial Literature

DOI: 10.1155/2013/450478

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text